NASDAQ$HCAT
Health Catalyst Inc · Q2 2022 earnings
Q2 2022 earnings · · Investor relations
Briefing
Reported strong financial performance, exceeding the mid-point of quarterly guidance for both revenue and Adjusted EBITDA.
Health Catalyst reported strong Q2 2022 financial results, exceeding revenue and Adjusted EBITDA guidance. However, the company revised down its revenue and Adjusted EBITDA outlook for the full year due to a challenging end market environment impacting bookings performance.
- Total revenue was $70.633 million, an 18% increase year-over-year.
- Technology revenue was $45.397 million, a 28% increase year-over-year.
- Professional services revenue was $25.236 million, a 5% increase year-over-year.
- Adjusted EBITDA was $1.999 million, a 20% increase year-over-year.
Headline financials
Revenue & EPS history
Health Catalyst · Revenue · Quarterly
$70.6M
Revenue by segment
Health Catalyst · $70.6M total across 2 segments · Q2 2022
- Technology$45.4M+27.8%64.3%
- Professional Services$25.2M+4.7%35.7%
Forward guidance
For Q3 2022, Health Catalyst expects total revenue between $65.3 million and $68.3 million, and Adjusted EBITDA between $(6.0) million and $(4.0) million. For the full year 2022, the company expects total revenue between $271.5 million and $275.5 million, and Adjusted EBITDA between $(6.0) million and $(4.0) million.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q2 2022
-3.1%
Avg return
Earnings day
-3.9%
Avg return
5 days after
-4.0%
Avg return
30 days after
41%
11 / 27 earnings
Positive
+27.3%
Q2 2024
Best reaction
-36.6%
Q2 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -9.9% | -21.7% | +4.6% | |
| Q4 2025 | -26.3% | -35.2% | -44.4% | |
| Q3 2025 | -5.6% | -20.5% | -10.2% | |
| Q1 2025 | +5.3% | +8.1% | +3.3% | |
| Q4 2024 | -11.1% | -8.5% | -7.9% | |
| Q3 2024 | +14.2% | +7.2% | +7.6% | |
| Q2 2024 | +27.3% | +7.3% | +22.9% | |
| Q1 2024 | -3.6% | +2.9% | -2.3% | |
| Q4 2023 | -14.7% | -8.9% | -14.4% | |
| Q3 2023 | +5.1% | -0.4% | +5.3% | |
| Q2 2023 | -8.0% | -5.0% | -12.4% | |
| Q1 2023 | -18.9% | -14.8% | -4.3% | |
| Q4 2022 | +7.3% | +5.8% | -14.8% | |
| Q3 2022 | +16.2% | +42.9% | +59.2% | |
| Q2 2022 | -36.6% | -34.7% | -35.9% | |
| Q1 2022 | -2.6% | +24.6% | +10.5% | |
| Q4 2021 | +1.5% | -7.1% | -3.7% | |
| Q3 2021 | -6.2% | -6.1% | -26.9% | |
| Q2 2021 | +1.5% | -2.3% | -2.8% | |
| Q1 2021 | -2.3% | -8.6% | -2.4% | |
| Q4 2020 | +0.6% | +0.1% | -2.1% | |
| Q3 2020 | -0.2% | -3.5% | +6.2% | |
| Q2 2020 | -7.2% | -10.9% | -3.4% | |
| Q1 2020 | -1.9% | -0.5% | -5.0% | |
| Q4 2019 | +1.3% | -5.8% | -20.1% | |
| Q3 2019 | +1.9% | -0.8% | -1.1% | |
| Q2 2019 | -11.5% | -7.8% | -13.1% | |
| Q4 2018 | — | — | — | |
| Q3 2018 | — | — | — | |
| Q2 2018 | — | — | — | |
| Q1 2018 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro